173 related articles for article (PubMed ID: 36098401)
1. Urolithin A attenuates severity of chronic pancreatitis associated with continued alcohol intake by inhibiting PI3K/AKT/mTOR signaling.
Mehra S; Srinivasan S; Singh S; Zhou Z; Garrido V; Silva IC; Totiger TM; Dosch AR; Dai X; Dawra RK; Jala VR; Shi C; Datta J; VanSaun M; Merchant N; Nagathihalli N
Am J Physiol Gastrointest Liver Physiol; 2022 Oct; 323(4):G375-G386. PubMed ID: 36098401
[TBL] [Abstract][Full Text] [Related]
2. P-element-Induced Wimpy-Testis-Like Protein 1 Regulates the Activation of Pancreatic Stellate Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Xue R; Zhou J; Wu J; Meng Q; Gong J; Shen L
Dig Dis Sci; 2023 Apr; 68(4):1339-1350. PubMed ID: 36002675
[TBL] [Abstract][Full Text] [Related]
3. Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer.
Totiger TM; Srinivasan S; Jala VR; Lamichhane P; Dosch AR; Gaidarski AA; Joshi C; Rangappa S; Castellanos J; Vemula PK; Chen X; Kwon D; Kashikar N; VanSaun M; Merchant NB; Nagathihalli NS
Mol Cancer Ther; 2019 Feb; 18(2):301-311. PubMed ID: 30404927
[TBL] [Abstract][Full Text] [Related]
4. Silencing of EPCAM suppresses hepatic fibrosis and hepatic stellate cell proliferation in mice with alcoholic hepatitis via the PI3K/Akt/mTOR signaling pathway.
Zhang Z; Wen H; Weng J; Feng L; Liu H; Hu X; Zeng F
Cell Cycle; 2019 Sep; 18(18):2239-2254. PubMed ID: 31378124
[TBL] [Abstract][Full Text] [Related]
5. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts.
Cao X; Kambe F; Moeller LC; Refetoff S; Seo H
Mol Endocrinol; 2005 Jan; 19(1):102-12. PubMed ID: 15388791
[TBL] [Abstract][Full Text] [Related]
6. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
7. PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis.
Faghiri Z; Bazan NG
Exp Eye Res; 2010 Jun; 90(6):718-25. PubMed ID: 20230819
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
Li YJ; Wang Y; Wang YY
J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
[TBL] [Abstract][Full Text] [Related]
9. Adipose‑derived mesenchymal stem cells ameliorate dibutyltin dichloride‑induced chronic pancreatitis by inhibiting the PI3K/AKT/mTOR signaling pathway.
Xu X; Yu H; Sun L; Zheng C; Shan Y; Zhou Z; Wang C; Chen B
Mol Med Rep; 2020 Apr; 21(4):1833-1840. PubMed ID: 32319628
[TBL] [Abstract][Full Text] [Related]
10. S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells.
Lee JE; Lim MS; Park JH; Park CH; Koh HC
Mol Neurobiol; 2016 Aug; 53(6):3771-3782. PubMed ID: 26143260
[TBL] [Abstract][Full Text] [Related]
11. Activation of autophagy and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia-ischemia.
Carloni S; Girelli S; Scopa C; Buonocore G; Longini M; Balduini W
Autophagy; 2010 Apr; 6(3):366-77. PubMed ID: 20168088
[TBL] [Abstract][Full Text] [Related]
12. Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.
Chamcheu JC; Adhami VM; Esnault S; Sechi M; Siddiqui IA; Satyshur KA; Syed DN; Dodwad SM; Chaves-Rodriquez MI; Longley BJ; Wood GS; Mukhtar H
Antioxid Redox Signal; 2017 Jan; 26(2):49-69. PubMed ID: 27393705
[TBL] [Abstract][Full Text] [Related]
13. The involvement of PI3K/Akt/mTOR/GSK3β signaling pathways in the antidepressant-like effect of AZD6765.
Neis VB; Moretti M; Rosa PB; Dalsenter YO; Werle I; Platt N; Kaufmann FN; Rosado AF; Besen MH; Rodrigues ALS
Pharmacol Biochem Behav; 2020 Nov; 198():173020. PubMed ID: 32861641
[TBL] [Abstract][Full Text] [Related]
14. L-threonine regulates G1/S phase transition of mouse embryonic stem cells via PI3K/Akt, MAPKs, and mTORC pathways.
Ryu JM; Han HJ
J Biol Chem; 2011 Jul; 286(27):23667-78. PubMed ID: 21550972
[TBL] [Abstract][Full Text] [Related]
15. Involvement of PI3K-AKT-mTOR pathway in protein kinase CKII inhibition-mediated senescence in human colon cancer cells.
Park JH; Kim JJ; Bae YS
Biochem Biophys Res Commun; 2013 Apr; 433(4):420-5. PubMed ID: 23523798
[TBL] [Abstract][Full Text] [Related]
16. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.
Sekulić A; Hudson CC; Homme JL; Yin P; Otterness DM; Karnitz LM; Abraham RT
Cancer Res; 2000 Jul; 60(13):3504-13. PubMed ID: 10910062
[TBL] [Abstract][Full Text] [Related]
17. Danshen injection induces autophagy in podocytes to alleviate nephrotic syndrome via the PI3K/AKT/mTOR pathway.
Chen J; Yuan S; Zhou J; Huang X; Wu W; Cao Y; Liu H; Hu Q; Li X; Guan X; Yin S; Jiang J; Zhou Y; Zhou J
Phytomedicine; 2022 Dec; 107():154477. PubMed ID: 36215790
[TBL] [Abstract][Full Text] [Related]
18. Effects of PI3K catalytic subunit and Akt isoform deficiency on mTOR and p70S6K activation in myoblasts.
Matheny RW; Adamo ML
Biochem Biophys Res Commun; 2009 Dec; 390(2):252-7. PubMed ID: 19799871
[TBL] [Abstract][Full Text] [Related]
19. The role of the PI3K/mTOR signaling pathway in Staphylococcus epidermidis small colony variants intracellular survival.
Magryś A; Bogut A; Kiełbus M; Olender A
Immunol Invest; 2018 Apr; 47(3):251-263. PubMed ID: 29336620
[TBL] [Abstract][Full Text] [Related]
20. Extracellular ATP-induced proliferation of adventitial fibroblasts requires phosphoinositide 3-kinase, Akt, mammalian target of rapamycin, and p70 S6 kinase signaling pathways.
Gerasimovskaya EV; Tucker DA; Weiser-Evans M; Wenzlau JM; Klemm DJ; Banks M; Stenmark KR
J Biol Chem; 2005 Jan; 280(3):1838-48. PubMed ID: 15522879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
